Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (231-240 of 310) with videos related to

Pageof 31
Sort By:
Nature Communications|January 7, 2023
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancersWalid K Chatila, Henry Walch, Jaclyn F Hechtman, et al.
Cancer Cell|January 10, 2018
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal CancerRona Yaeger, Walid K Chatila, Marla D Lipsyc, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian CarcinomaTanjina Kader, Jia-Ren Lin, Clemens Hug, et al.
Neuro-Oncology|May 5, 2017
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendrogliomaAlissa A Thomas, Lauren E Abrey, Robert Terziev, et al.
Oncogene|April 24, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Cell|December 19, 2024
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancerMark Zucker, Maria A Perry, Samuel I Gould, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non-Small Cell Lung CancerNoura J Choudhury, Jessica A Lavery, Samantha Brown, et al.
The Lancet. Oncology|May 22, 2020
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trialYelena Y Janjigian, Steven B Maron, Walid K Chatila, et al.
Research Square|January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Pageof 31

Showing results (231-240 of 310) with videos related to

Sort By:
Pageof 31
Nature Communications|January 7, 2023
Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancersWalid K Chatila, Henry Walch, Jaclyn F Hechtman, et al.
Cancer Cell|January 10, 2018
Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal CancerRona Yaeger, Walid K Chatila, Marla D Lipsyc, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian CarcinomaTanjina Kader, Jia-Ren Lin, Clemens Hug, et al.
Neuro-Oncology|May 5, 2017
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendrogliomaAlissa A Thomas, Lauren E Abrey, Robert Terziev, et al.
Oncogene|April 24, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
Cell|December 19, 2024
Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancerMark Zucker, Maria A Perry, Samuel I Gould, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non-Small Cell Lung CancerNoura J Choudhury, Jessica A Lavery, Samantha Brown, et al.
The Lancet. Oncology|May 22, 2020
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trialYelena Y Janjigian, Steven B Maron, Walid K Chatila, et al.
Research Square|January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responsesZhiping Li, Xuanmao Jiao, A Gordon Robertson, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Pageof 31